Theolytics

Oxford, United Kingdom

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

$9.3M raised

Mar 2026

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Theolytics raised?

Theolytics has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.

Who are Theolytics's investors?

Theolytics's investors include Epidarex Capital, Oxford Science Enterprises, Taiho Ventures, Sound Bioventures, Innovate UK.

Where is Theolytics headquartered?

Theolytics is headquartered in Oxford, United Kingdom.

What does Theolytics do?

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

What stage is Theolytics at?

Theolytics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 4, 2026.

MLA

"Theolytics — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/theolytics. Accessed July 2, 2026.

APA

VCBacked. (2026). Theolytics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/theolytics

Wikipedia (cite web)

{{cite web |title=Theolytics — Funding & Investors |url=https://www.vcbacked.co/company/theolytics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 4, 2026.